Allelic and locus heterogeneity in inherited venous malformations
- PMID: 10369874
- DOI: 10.1093/hmg/8.7.1279
Allelic and locus heterogeneity in inherited venous malformations
Abstract
Venous malformations are low-flow vascular lesions consisting of disorganized thin-walled vascular channels. These can occur sporadically but also as an autosomal dominant condition termed venous malformations, cutaneous and mucosal (VMCM; OMIM 600195). In two large unrelated kindreds mapping to chromosome 9, the identical R849W missense mutation was identified in the first kinase domain of Tie2, an endothelial cell-specific receptor tyrosine kinase. We report here the identification of four new kindreds with inherited venous malformations. Unlike the initial two families described, these four families demonstrate allelic and locus heterogeneity. In one of these families, the R849W mutation co-segregates with the disease phenotype. Three other families with venous malformations lack this mutation. One of these families is linked to markers near TIE2 on chromosome 9. In this family, we identified a novel mutation within the first kinase domain of Tie2 resulting in a Y897S change. Results from COS-1 cell transfections using expression constructs containing either the R849W or the Y897S mutation suggest that the receptors containing either mutation show ligand-independent hyperphosphorylation. These results suggest a gain-of-function mechanism for development of venous malformations in these families. Of the two remaining families, one excludes linkage to the TIE2 locus, establishing the existence of at least one additional locus for dominantly inherited venous malformations.
Similar articles
-
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.Eur J Hum Genet. 2010 Apr;18(4):414-20. doi: 10.1038/ejhg.2009.193. Epub 2009 Nov 4. Eur J Hum Genet. 2010. PMID: 19888299 Free PMC article.
-
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.Cell. 1996 Dec 27;87(7):1181-90. doi: 10.1016/s0092-8674(00)81814-0. Cell. 1996. PMID: 8980225
-
STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.Angiogenesis. 2013 Jan;16(1):207-22. doi: 10.1007/s10456-012-9313-x. Epub 2012 Oct 21. Angiogenesis. 2013. PMID: 23086340
-
Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):740-748. doi: 10.1016/j.jvsv.2017.05.001. Epub 2017 May 16. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28818232 Review.
-
The genetics of vascular anomalies.Curr Opin Otolaryngol Head Neck Surg. 2012 Dec;20(6):527-32. doi: 10.1097/MOO.0b013e3283587415. Curr Opin Otolaryngol Head Neck Surg. 2012. PMID: 22913934 Review.
Cited by
-
Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas").Am J Hum Genet. 2002 Apr;70(4):866-74. doi: 10.1086/339492. Epub 2002 Feb 13. Am J Hum Genet. 2002. PMID: 11845407 Free PMC article.
-
Genetic aspects of cerebrovascular malformations.Interv Neuroradiol. 2000 Jun 30;6(2):107-11. doi: 10.1177/159101990000600204. Epub 2001 May 15. Interv Neuroradiol. 2000. PMID: 20667188 Free PMC article.
-
A Tie2 kinase mutation causing venous malformations increases phosphorylation rates and enhances cooperativity.Biochem Biophys Res Commun. 2019 Feb 19;509(4):898-902. doi: 10.1016/j.bbrc.2019.01.020. Epub 2019 Jan 11. Biochem Biophys Res Commun. 2019. PMID: 30638931 Free PMC article.
-
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.Orphanet J Rare Dis. 2018 Oct 29;13(1):191. doi: 10.1186/s13023-018-0934-z. Orphanet J Rare Dis. 2018. PMID: 30373605 Free PMC article.
-
Pathogenesis of vascular anomalies.Clin Plast Surg. 2011 Jan;38(1):7-19. doi: 10.1016/j.cps.2010.08.012. Clin Plast Surg. 2011. PMID: 21095468 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous